| Literature DB >> 30805511 |
Helena C Maltezou1, Xanthi Dedoukou1, Hara Asimaki2, Ioanna Kontou2, Loukia Ioannidou2, Konstantina Mitromara2, Kalliopi Theodoridou2, Panos Katerelos1, Maria Theodoridou2.
Abstract
BACKGROUND: Greece is among the European countries with the highest consumption of antibiotics.Entities:
Keywords: Antibiotics; Children; Community; Consumption; Pediatrics
Year: 2017 PMID: 30805511 PMCID: PMC6372488 DOI: 10.1016/j.ijpam.2017.04.002
Source DB: PubMed Journal: Int J Pediatr Adolesc Med ISSN: 2352-6467
Characteristics of parents.
| Characteristic | Parents N = 287 (%) |
|---|---|
| Mean age, years (range) (n = 275) | 35.8 (16–57) |
| Level of education (n = 286) | |
| Illiterate or elementary school | 39 (13.6) |
| Secondary school | 44 (15.4) |
| High school | 82 (28.7) |
| Technologic institution/University | 104 (36.4) |
| Unknown | 17 (5.9) |
| Roma population (n = 287) | 34 (11.8) |
| Immigrants (n = 287) | 56 (19.5) |
| Unemployed (n = 287) | 47 (16.4) |
| Urban area of residence (n = 285) | 264 (92.6) |
| Mean no. of family members (range) (n = 281) | 4.1 (2–10) |
| Mean no. of children in the family (range) (n = 287) | 1.9 (1–9) |
n: number of parents for whom an answer was available.
Antibiotic consumption by children in the community in Greece per clinical indication.
| Clinical indication/Antibiotic* | n (%) N = 465 |
|---|---|
| Amoxicillin | 41 (32.3) |
| Amoxicillin/clavulanate | 38 (29.9) |
| 2nd generation cephalosporin | 28 (22.1) |
| Clarithromycin | 9 (7.1) |
| Unknown | 11 (8.7) |
| Amoxicillin/clavulanate | 6 (30.5) |
| Amoxicillin | 32 (27.1) |
| Clarithromycin or azithromycin | 27 (22.9) |
| 2nd generation cephalosporin | 14 (11.9) |
| Unknown | 9 (7.6) |
| Clarithromycin | 23 (27.7) |
| 2nd generation cephalosporin | 17 (20.5) |
| Amoxycillin/clavulanate | 15 (18.1) |
| Azithromycin | 5 (6.0) |
| Amoxycillin | 4 (4.8) |
| Unknown | 19 (22.9) |
| Amoxicillin/clavulanate | 5 (35.7) |
| Cefuroxime | 4 (28.6) |
| Cefaclor | 1 (28.6) |
| Amoxycillin | 1 (7.1) |
| Unknown | 3 (21.4) |
| Amoxicillin | 4 (36.4) |
| Amoxicillin/clavulanate | 2 (18.2) |
| Clarithromycin | 2 (18.2) |
| Cefuroxime | 1 (9.1) |
| Unknown | 2 (18.2) |
| Amoxicillin/clavulanate | 4 (36.4) |
| Clarithromyicin | 3 (27.3) |
| 2nd generation cephalosporin | 1 (9.1) |
| Unknown | 3 (27.3) |
* Clinical indications with at least 10 antibiotic courses are presented.